Madison Investment Advisors’s Pfizer PFE Stock Holding History

Madison Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$5.36M	Buy	+202,029	New	+$5.48M	0.06%	162

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Madison Investment Advisors's PFE Position: Q4 2024 in Review

Madison Investment Advisors opened a new position in Pfizer (PFE) in Q4 2024: 202,029 shares worth $5.36M. The stake represents 0.06% of the portfolio and ranks #162 among its holdings.

3,001 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Madison Investment Advisors held 202,029 shares of Pfizer worth $5.36M as of Q4 2024.
Pfizer was a new Madison Investment Advisors position in Q4 2024.
Pfizer made up 0.06% of Madison Investment Advisors's portfolio in Q4 2024, its #162 holding.
3,001 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Madison Investment Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.